Cerus Corporation

Last updated September 27, 2026

Organization details

Legal name
Cerus Corporation
Ownership
Public
Status
Active
SIC code
3841 โ€” Surgical & Medical Instruments & Apparatus
Jurisdiction of incorporation
Delaware
Headquarters city
Concord
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
CERS
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001020214
EIN
68-0262011

Board of directors

Chief executives

William Mariner Greenman ยท President and CEO
Dates unknown

Director election results

Annual meeting of June 2, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

5 of this board's directors also sit on 10 other boards.

Network of Cerus Corporation's board connections Alamar Biosciences Inc. Alamar Biosciences Inc... BioLife Solutions Inc. BioLife Solutions Inc. CalciMedica Inc. CalciMedica Inc. Corcept Therapeutics Incorporated Corcept Therapeutics I... Intuitive Surgical Inc. Intuitive Surgical Inc... Metagenomi Therapeutics Inc. Metagenomi Therapeutic... Protagonist Therapeutics Inc. Protagonist Therapeuti... Revvity Inc. Revvity Inc. Standard BioTools Inc. Standard BioTools Inc. Surrozen Inc. Surrozen Inc. Daniel N. Swisher Jr. Daniel N. Swisher Jr... Eric Bjerkholt Eric Bjerkholt Frank Witney Frank Witney Jami K. Nachtsheim Jami K. Nachtsheim Timothy L. Moore Timothy L. Moore Cerus Corporation
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$3,090,465
22 sales by 6 insiders
Date Insider Transaction Shares Price Value
Aug 17, 2026 Jensen Chrystal Officer (Chief Legal Officer) Open-market sale โˆ’30,000 $2.98 $89,529
Jul 16, 2026 Jayaraman Vivek K Officer (Chief Executive Officer) Open-market sale โˆ’16,666 $3.16 $52,665
Jul 1, 2026 Jayaraman Vivek K Officer (Chief Operating Officer) Grant or award +554,529 โ€” โ€”
Jun 30, 2026 William Mariner Greenman Director, Officer (President and CEO) Grant or award โˆ’192,500 โ€” โ€”
Jun 30, 2026 Green Kevin Dennis Officer (Chief Financial Officer) Grant or award โˆ’63,600 โ€” โ€”
Jun 30, 2026 Jensen Chrystal Officer (Chief Legal Officer) Grant or award โˆ’55,000 โ€” โ€”
Jun 30, 2026 Jayaraman Vivek K Officer (Chief Operating Officer) Grant or award โˆ’80,000 โ€” โ€”
Jun 30, 2026 William Mariner Greenman Director, Officer (President and CEO) Open-market sale โˆ’101,919 $2.94 $299,937
Jun 30, 2026 Green Kevin Dennis Officer (Chief Financial Officer) Open-market sale โˆ’33,676 $2.94 $99,105
Jun 30, 2026 Jensen Chrystal Officer (Chief Legal Officer) Open-market sale โˆ’24,329 $2.94 $71,598
Jun 30, 2026 Jayaraman Vivek K Officer (Chief Operating Officer) Open-market sale โˆ’42,359 $2.94 $124,658
Jun 9, 2026 Eric Bjerkholt Director Open-market sale โˆ’20,454 $2.60 $53,180
Jun 2, 2026 Ann Lucena Director Grant or award +60,000 โ€” โ€”
Jun 2, 2026 Eric Bjerkholt Director Grant or award +60,000 โ€” โ€”
Jun 2, 2026 Jami K. Nachtsheim Director Grant or award +60,000 โ€” โ€”

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.